The involvement of heat shock proteins in immune response is categoriz
ed into four distinct paradigms. In the First Paradigm, HSP derived fr
om foreign organisms act as classical foreign antigens, and they elici
t immune response to the non-conserved HSP epitopes. The Second Paradi
gm refers to instances where the host responds to self HSP to which th
ere is no central or peripheral tolerance. The Third Paradigm involves
molecular mimicry, where cross-reactivity between an HSP and another
protein leads to an immune response to the latter under conditions whi
ch elicit an immune response to the former, such as infection with a b
acterium whose immunodominant antigen is an HSP. The Fourth Paradigm r
efers to situations where an HSP-antigen complex elicits an effective
response to the antigen and not to the HSP. Thus the HSP acts as a car
rier for the antigenic peptide. The role of HSP in recognition by gamm
a delta T cells may also fall into this paradigm. In this article, the
Fourth Paradigm is considered as a crucial element in the development
of vaccines against cancers and infectious diseases, and is analyzed
through the prism of the observed association of hsp70 species with an
tigenic peptides.